|
ES2053549T3
(es)
|
1986-08-11 |
1994-08-01 |
Innovata Biomed Ltd |
Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.
|
|
US5179079A
(en)
|
1986-12-16 |
1993-01-12 |
Novo Nordisk A/S |
Nasal formulation and intranasal administration therewith
|
|
GB8723846D0
(en)
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
|
US5571714A
(en)
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
EP0460064A4
(en)
|
1989-02-23 |
1992-04-01 |
Rorer International (Holdings) Inc. |
Therapeutic aerosol formulations
|
|
GB8921222D0
(en)
|
1989-09-20 |
1989-11-08 |
Riker Laboratories Inc |
Medicinal aerosol formulations
|
|
US5731424A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
|
US5731144A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands
|
|
US5230884A
(en)
|
1990-09-11 |
1993-07-27 |
University Of Wales College Of Cardiff |
Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
|
|
US5292499A
(en)
|
1990-09-11 |
1994-03-08 |
University Of Wales College Of Cardiff |
Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
|
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
CH689139A5
(de)
|
1995-04-03 |
1998-10-30 |
Cerbios Pharma Sa |
Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
|
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
|
US5635161A
(en)
|
1995-06-07 |
1997-06-03 |
Abbott Laboratories |
Aerosol drug formulations containing vegetable oils
|
|
US6120794A
(en)
|
1995-09-26 |
2000-09-19 |
University Of Pittsburgh |
Emulsion and micellar formulations for the delivery of biologically active substances to cells
|
|
ATE243998T1
(de)
|
1995-10-12 |
2003-07-15 |
Supergen Inc |
Liposomformulierung von 5-beta steroiden
|
|
AU744939B2
(en)
*
|
1997-09-26 |
2002-03-07 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
|
US6806358B1
(en)
|
1997-12-16 |
2004-10-19 |
University Of California San Diego |
Peptide inhibitor of TGF-β growth factors
|
|
AU760046B2
(en)
|
1998-02-27 |
2003-05-08 |
United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
|
|
GB9809869D0
(en)
|
1998-05-09 |
1998-07-08 |
Medical Res Council |
Inhibition of protein kinases
|
|
JP2002535242A
(ja)
|
1998-05-20 |
2002-10-22 |
ザ リポソーム カンパニー、インコーポレーテッド |
新規な粒子状剤型
|
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
|
US6451349B1
(en)
|
1998-08-19 |
2002-09-17 |
Quadrant Healthcare (Uk) Limited |
Spray-drying process for the preparation of microparticles
|
|
AUPP494798A0
(en)
|
1998-07-29 |
1998-08-20 |
Pacific Biolink Pty Limited |
Protective protein formulation
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
US6290987B1
(en)
|
1998-09-27 |
2001-09-18 |
Generex Pharmaceuticals, Inc. |
Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
|
|
ES2146552B1
(es)
|
1998-11-24 |
2001-04-16 |
Inst Cientifico Tecnol Navarra |
Peptidos inhibidores de tgf/31
|
|
EP1338272A1
(en)
|
1998-12-21 |
2003-08-27 |
Generex Pharmaceuticals Inc. |
Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
|
|
US6436367B1
(en)
|
1998-12-21 |
2002-08-20 |
Generex Pharmaceuticals Inc. |
Aerosol formulations for buccal and pulmonary application
|
|
US6294153B1
(en)
|
1998-12-21 |
2001-09-25 |
Generex Pharmaceuticals, Inc. |
Aerosol pharmaceutical formulation for pulmonary and nasal delivery
|
|
AU2879100A
(en)
|
1999-02-12 |
2000-08-29 |
Miles A. Libbey Iii |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
|
AU3957400A
(en)
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
US6492497B1
(en)
|
1999-04-30 |
2002-12-10 |
Cambridge Antibody Technology Limited |
Specific binding members for TGFbeta1
|
|
AU5936400A
(en)
|
1999-06-04 |
2000-12-28 |
Delrx Pharmaceutical Corporation |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
|
US20010036481A1
(en)
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
CA2382821A1
(en)
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
|
BR0107764A
(pt)
|
2000-01-20 |
2002-11-12 |
Basilea Pharmaceutica Ag |
Composições de peptìdeo cìclico nasalmente administráveis
|
|
EP1129705A1
(en)
|
2000-02-17 |
2001-09-05 |
Rijksuniversiteit te Groningen |
Powder formulation for inhalation
|
|
JP2004500424A
(ja)
|
2000-04-17 |
2004-01-08 |
ヴェクトゥラ リミテッド |
吸入器で使用するための製剤
|
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
|
US20020155084A1
(en)
|
2000-06-02 |
2002-10-24 |
The Regents Of The University Of The Michigan |
Nanoemulsion formulations
|
|
US6509318B1
(en)
|
2000-09-29 |
2003-01-21 |
The Regents Of The University Of California |
TGF-B inhibitors and methods
|
|
FI20002768L
(fi)
|
2000-12-18 |
2002-06-19 |
Licentia Oy |
Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
|
|
US20030134836A1
(en)
*
|
2001-01-12 |
2003-07-17 |
Amgen Inc. |
Substituted arylamine derivatives and methods of use
|
|
GB0107106D0
(en)
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
|
SI1397364T1
(sl)
|
2001-05-24 |
2007-12-31 |
Lilly Co Eli |
Novi pirolni derivati kot farmacevtske uäśinkovine
|
|
US20030019437A1
(en)
|
2001-07-26 |
2003-01-30 |
John Fore |
Ungulate game animal feed system and method
|
|
US20030028905A1
(en)
|
2001-07-31 |
2003-02-06 |
Petra Knaus |
Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
|
|
US20030064033A1
(en)
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
CA2478974C
(en)
|
2002-03-20 |
2014-12-16 |
Advanced Inhalation Research, Inc. |
Inhalable sustained therapeutic formulations
|
|
DE60307082D1
(de)
|
2002-05-07 |
2006-09-07 |
Ferring Bv |
In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
|
|
JP2005530800A
(ja)
|
2002-05-15 |
2005-10-13 |
スミスクライン・ビーチャム・コーポレイション |
ベンゾオキサジンおよびベンゾオキサジノン置換トリアゾール
|
|
AU2003229305A1
(en)
|
2002-05-17 |
2003-12-02 |
Scios, Inc. |
TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-Beta INHIBITORS
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
EP1539748A1
(en)
|
2002-07-31 |
2005-06-15 |
Smithkline Beecham Corporation |
2-phenylpyridin-4-yl derivatives as alk5 inhibitors
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
WO2004026871A1
(en)
|
2002-09-17 |
2004-04-01 |
Eli Lilly And Company |
Novel pyrazolopyridine derivatves as pharmaceutical agents
|
|
KR20050057441A
(ko)
|
2002-09-18 |
2005-06-16 |
화이자 프로덕츠 인코포레이티드 |
전환 성장 인자 억제제로서의 신규한 아이소티아졸 및아이속사졸 화합물
|
|
JP2006502236A
(ja)
|
2002-09-18 |
2006-01-19 |
ファイザー・プロダクツ・インク |
形質転換成長因子(tgf)阻害剤としてのトリアゾール誘導体
|
|
WO2004047818A2
(en)
|
2002-11-22 |
2004-06-10 |
Scios, Inc. |
USE OF TFG-β INHIBITORSTO COUNTERACT PATHOLOGIC CHANGES IN THE LEVEL OR FUNCTION OF STEROID/THYROID RECEPTORS
|
|
JP4896518B2
(ja)
*
|
2002-12-13 |
2012-03-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
ニコチンアミド系キナーゼ阻害薬
|
|
JP2006516603A
(ja)
|
2003-01-27 |
2006-07-06 |
ファイザー・プロダクツ・インク |
イソチアゾール誘導体
|
|
DE602004014347D1
(de)
|
2003-03-12 |
2008-07-24 |
Millennium Pharm Inc |
Chinazolin-derivate als tgf-beta-inhibitoren
|
|
EP1608631A4
(en)
|
2003-03-28 |
2008-08-20 |
Scios Inc |
BICYCLIC PYRIMIDININHIBITORS OF TGF BETA
|
|
ES2389258T3
(es)
|
2003-06-17 |
2012-10-24 |
Millennium Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir TGF-s
|
|
EP1644365A2
(en)
*
|
2003-07-02 |
2006-04-12 |
Biofocus Discovery Ltd |
Pyrazine and pyridine derivatives as rho kinase inhibitors
|
|
JP4688680B2
(ja)
|
2003-10-28 |
2011-05-25 |
独立行政法人理化学研究所 |
TGF−β情報伝達経路阻害剤
|
|
CA2551524A1
(en)
|
2003-12-24 |
2005-07-21 |
Scios, Inc. |
Treatment of malignant gliomas with tgf-beta inhibitors
|
|
US7368445B2
(en)
|
2004-03-01 |
2008-05-06 |
Eli Lilly And Company |
Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
|
|
US20090196912A1
(en)
*
|
2004-07-30 |
2009-08-06 |
Gpc Botech Ag |
Pyridinylamines
|
|
JP2007176795A
(ja)
|
2004-08-18 |
2007-07-12 |
Univ Nihon |
TGF−β遺伝子発現抑制剤
|
|
CN101189234B
(zh)
|
2005-03-25 |
2011-08-17 |
泰博特克药品有限公司 |
Hcv的杂二环抑制剂
|
|
CA2616196C
(en)
|
2005-07-22 |
2012-08-21 |
Eli Lilly And Company |
A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor
|
|
AU2005337776B2
(en)
|
2005-10-24 |
2013-01-31 |
Proyecto De Biomedicina Cima, S.L. |
Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent
|
|
WO2007084667A2
(en)
*
|
2006-01-19 |
2007-07-26 |
Osi Pharmaceutical, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
ITMI20060181A1
(it)
|
2006-02-03 |
2007-08-04 |
Univ Padova |
Modulatori del tgf-b e loro uso
|
|
BRPI0807961A2
(pt)
*
|
2007-02-13 |
2017-05-16 |
Pharmacopeia Llc |
agonista de alfa2c adrenorreceptor funcionalmente seletivos.
|
|
EP2197876A1
(en)
|
2007-08-29 |
2010-06-23 |
Glaxosmithkline LLC |
Thiazole and oxazole kinase inhibitors
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
GB0821307D0
(en)
*
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
AU2010247412A1
(en)
*
|
2009-05-15 |
2011-11-24 |
Novartis Ag |
5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1
|
|
EP2763976B1
(en)
*
|
2011-10-05 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
WO2014018691A1
(en)
|
2012-07-24 |
2014-01-30 |
The Trustees Of Columbia University In The City Of New York |
Generation of airway and lung progenitors and epithelial cells and three-dimensional anterior foregut spheres
|
|
CN105142621A
(zh)
*
|
2012-10-24 |
2015-12-09 |
国家健康科学研究所 |
用于预防或治疗糖尿病和促进β-细胞存活的TPL2激酶抑制剂
|
|
MX2015007097A
(es)
*
|
2012-12-10 |
2015-09-29 |
Hoffmann La Roche |
Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.
|
|
GB2519623A
(en)
*
|
2013-06-18 |
2015-04-29 |
4Sc Discovery Gmbh |
Method of inhibiting DYRK1B
|
|
US9725463B2
(en)
*
|
2013-06-21 |
2017-08-08 |
Lupin Limited |
Substituted heterocyclic compounds as CRAC modulators
|
|
US20170280720A1
(en)
*
|
2014-09-17 |
2017-10-05 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
|
KR20170141767A
(ko)
*
|
2015-04-29 |
2017-12-26 |
얀센 파마슈티카 엔.브이. |
벤즈이미다졸론 및 벤조티아졸론 화합물 및 ampa 수용체 조절제로서의 이들의 용도
|
|
WO2017008694A1
(zh)
|
2015-07-11 |
2017-01-19 |
常州合力电器有限公司 |
直流松土机
|
|
US11332716B2
(en)
*
|
2015-07-27 |
2022-05-17 |
The Regents Of The University Of California |
Methods and compositions for producing pancreatic beta cells
|
|
AU2016315881B2
(en)
*
|
2015-09-03 |
2019-09-19 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of DYRK1A and uses thereof
|
|
EP3389720A1
(en)
*
|
2015-12-18 |
2018-10-24 |
The General Hospital Corporation |
Polyacetal polymers, conjugates, particles and uses thereof
|
|
US10487087B2
(en)
|
2015-12-30 |
2019-11-26 |
Vanderbilt University |
Positive allosteric modulators of the GLP-1 receptor
|
|
JP6596390B2
(ja)
|
2016-06-29 |
2019-10-23 |
株式会社沖データ |
現像剤収容器、現像装置、画像形成装置、及び基板支持構造
|